1. The interaction between PLEKHG2 and ABL1 suppresses cell growth via the NF-κB signaling pathway in HEK293 cells.
- Author
-
Nishikawa M, Nakano S, Nakao H, Sato K, Sugiyama T, Akao Y, Nagaoka H, Yamakawa H, Nagase T, and Ueda H
- Subjects
- Actin Cytoskeleton metabolism, Actins metabolism, Fusion Proteins, bcr-abl metabolism, Guanine Nucleotide Exchange Factors genetics, HEK293 Cells, Humans, NF-KappaB Inhibitor alpha metabolism, Phosphorylation genetics, Protein Aggregates genetics, Protein Binding genetics, Proto-Oncogene Proteins c-abl genetics, Serum Response Element genetics, Transcription, Genetic genetics, Transfection, Cell Proliferation genetics, Guanine Nucleotide Exchange Factors metabolism, NF-kappa B metabolism, Proto-Oncogene Proteins c-abl metabolism, Signal Transduction genetics
- Abstract
The Rho family small GTPases mediate cell responses through actin cytoskeletal rearrangement. We previously reported that PLEKHG2, a Rho-specific guanine nucleotide exchange factor, is regulated via interaction with several proteins. We found that PLEKHG2 interacted with non-receptor tyrosine kinase ABL1, but the cellular function remains unclear. Here, we show that the interaction between PLEKHG2 and ABL1 attenuated the PLEKHG2-induced serum response element-dependent gene transcription in a tyrosine phosphorylation-independent manner. PLEKHG2 and ABL1 were co-localized and accumulated within cells co-expressing PLEKHG2 and ABL1. The cellular fractionation analysis suggested that the accumulation involved actin cytoskeletal reorganization. We also revealed that the co-expression of PLEKHG2 with ABL1, but not BCR-ABL, suppressed cell growth and synergistically enhanced NF-κB-dependent gene transcription. The cell growth suppression was canceled by co-expression with IκBα, a member of the NF-κB inhibitor protein family. This study suggests that the interaction between PLEKHG2 and ABL1 suppresses cell growth through intracellular protein accumulation via the NF-κB signaling pathway., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF